Zach Sweeney
InvestorVenture Partner at Versant Ventures
About
Venture Partner at Versant with extensive experience leading drug discovery across small molecule, biotherapeutic, and technology platforms. Previously co-founded and served as CEO of Interline Therapeutics, was CSO of Denali Therapeutics, and held drug discovery leadership roles at Genentech, Roche, Novartis, and Revolution Medicines. He works with entrepreneurs to build new companies from early-stage science.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures